Zobrazeno 1 - 10
of 873
pro vyhledávání: '"Barcelona Clinic Liver Cancer"'
Autor:
Mohamed Kohla, Reham Ashour, Hossam Taha, Osama El-Abd, Maher Osman, Mai Abozeid, Sally Waheed ELKhadry
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Accurate staging is necessary for predicting hepatocellular carcinoma (HCC) prognosis and guiding patient management. The Barcelona Clinic Liver Cancer (BCLC) staging system has limitations due to heterogeneity observed among pati
Externí odkaz:
https://doaj.org/article/6c6b8dcc52aa45c2a1533daae45b509a
Autor:
Jiwon Yang, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Deok-Bog Moon, Dong-Hwan Jung, Jonggi Choi
Publikováno v:
Journal of Liver Cancer, Vol 24, Iss 2, Pp 178-191 (2024)
Backgrounds/Aims This study aimed to compare the outcomes of liver resection (LR) and transarterial chemoembolization (TACE) in patients with multinodular hepatocellular carcinoma (HCC) within the Milan criteria who were not eligible for liver transp
Externí odkaz:
https://doaj.org/article/c22de94c68384f86b3e2181885101dfc
Publikováno v:
Cancer Medicine, Vol 13, Iss 18, Pp n/a-n/a (2024)
Abstract Introduction This study aimed to evaluate the efficacy and safety of atezolizumab combined with bevacizumab (Atez/Bev) compared to lenvatinib (LEN) as first‐line systemic therapy for patients with Barcelona Clinic Liver Cancer (BCLC) stage
Externí odkaz:
https://doaj.org/article/b32b164f362647f7ba3fc1cf8d2a5030
Publikováno v:
Current Oncology, Vol 31, Iss 2, Pp 617-628 (2024)
The application of trans-arterial radioembolization (TARE) with Yttrium-90, historically a palliative treatment option for patients with advanced hepatocellular carcinoma (HCC), is evolving. Radiation segmentectomy (RADSEG), the segmental delivery of
Externí odkaz:
https://doaj.org/article/bdb5e220e04e432da0983f19b2c3caa7
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 11, Pp 51-64 (2024)
Ruyu Han,* Leijuan Gan,* Mengran Lang,* Guangtao Li, Lu Chen, Xindi Tian, Kangwei Zhu, Liyu Sun, Tianqiang Song Department of Hepatobiliary Cancer, Liver Cancer Center, Tianjin Medical University Cancer Institute & Hospital, National Clin
Externí odkaz:
https://doaj.org/article/c477a934616e455286575c88444d96f5
Autor:
Heechul Nam, Pil Soo Sung, Sung Won Lee, Do Seon Song, Jung Hyun Kwon, Jeong Won Jang, Chang Wook Kim, Si Hyun Bae
Publikováno v:
Liver Cancer, Pp 1-1 (2024)
Introduction: Despite its prognostic impact, nutritional status has not yet been integrated into the assessment of hepatocellular carcinoma (HCC). This study investigated the association between geriatric nutritional risk index (GNRI) and overall sur
Externí odkaz:
https://doaj.org/article/017ae29a2430451fa275a24cc5ba3610
Autor:
Julia Wagenpfeil, Patrick Arthur Kupczyk, Philipp Bruners, Robert Siepmann, Emelie Guendel, Julian Alexander Luetkens, Alexander Isaak, Carsten Meyer, Fabian Kuetting, Claus Christian Pieper, Ulrike Irmgard Attenberger, Daniel Kuetting
Publikováno v:
Frontiers in Radiology, Vol 4 (2024)
PurposeDue to a lack of data, there is an ongoing debate regarding the optimal frontline interventional therapy for unresectable hepatocellular carcinoma (HCC). The aim of the study is to compare the results of transarterial radioembolization (TARE)
Externí odkaz:
https://doaj.org/article/2a4cc9fc5c3e4470bf0bc7603aa1ec58
Publikováno v:
Clinical and Molecular Hepatology, Vol 29, Iss 2, Pp 230-241 (2023)
Hepatocellular carcinoma (HCC) is the fourth most common cancer and the second leading cause of cancer-related death in Taiwan. The Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan developed and updated the guidelines for
Externí odkaz:
https://doaj.org/article/7855b3a931c74e0d92755983dfd82f81
Autor:
Osman HA, Nafady-Hego H, Nasif KA, Ahmed HA, Mahmoud EAR, Abass NM, Rayan A, Mahmoud MA, Nafady A
Publikováno v:
International Journal of General Medicine, Vol Volume 16, Pp 1047-1058 (2023)
Heba Ahmed Osman,1 Hanaa Nafady-Hego,2 Khalid Ali Nasif,3,4 Heba A Ahmed,5 Ekram Abdel-Rahman Mahmoud,6 Noher Mohamad Abass,7 Amal Rayan,8 Marwa Ahmed Mahmoud,9 Asmaa Nafady10 1Department of Tropical Medicine and Gastroenterology, Qena Faculty of Med
Externí odkaz:
https://doaj.org/article/358f6e410f7243fcaa1cd04b83809e2d
Autor:
Kenta Yamamoto, Takashi Honda, Yosuke Inukai, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Hiroki Kawashima
Publikováno v:
Microorganisms, Vol 12, Iss 3, p 610 (2024)
We investigated the prognostic role of the gut microbiome and clinical factors in chronic liver disease (hepatitis, cirrhosis, and hepatocellular carcinoma [HCC]). Utilizing data from 227 patients whose stool samples were collected over the prior 3 y
Externí odkaz:
https://doaj.org/article/e53bec5a81254deba5733dc790a437d9